2023-11-21 | Sale | Bolt Biotherapeutics, Inc. BOLT | 10 percent owner | | $0.90 | $3,060 | -10.77% | |
2023-11-20 | Sale | Bolt Biotherapeutics, Inc. BOLT | 10 percent owner | | $0.92 | $50,324 | -15.33% | |
2023-11-17 | Sale | Bolt Biotherapeutics, Inc. BOLT | 10 percent owner | | $0.93 | $15,209 | -16.4% | |
2023-11-16 | Sale | Bolt Biotherapeutics, Inc. BOLT | 10 percent owner | | $0.96 | $14,400 | -16.84% | |
2021-02-09 | Sale | Bolt Biotherapeutics, Inc. BOLT | 10 percent owner | | $20.00 | $4,520 | -58.82% | |
2021-02-09 | Purchase | Bolt Biotherapeutics, Inc. BOLT | 10 percent owner | | $20.00 | $7M | -58.82% | |
2021-02-09 | Purchase | Terns Pharmaceuticals, Inc. TERN | 10 percent owner | | $17.00 | $8.07M | -48.44% | |
2020-10-20 | Purchase | Aligos Therapeutics, Inc. ALGS | 10 percent owner | | $15.00 | $8.25M | +61.44% | |
2020-04-17 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | | $15.40 | $1.3M | +0.52% | |
2020-04-16 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | | $15.20 | $458,888 | -0.42% | |
2020-04-15 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | | $15.50 | $3.35M | -0.42% | |
2020-04-07 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | | $14.20 | $86,833 | +17.71% | |
2020-04-03 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | | $13.80 | $4.14M | +16.11% | |
2020-03-09 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | | $19.50 | $10,296 | -20.15% | |
2020-02-10 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | | $21.40 | $161,677 | -29.01% | |
2020-02-07 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | | $22.00 | $129,910 | -29.7% | |
2020-02-04 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | | $22.80 | $554,861 | -31.63% | |
2020-01-31 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | | $21.70 | $234,360 | -29.05% | |
2020-01-30 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | | $22.10 | $335,920 | -31.04% | |
2020-01-29 | Sale | Crinetics Pharmaceuticals, Inc. CRNX | 10 percent owner | | $22.20 | $618,048 | -31.03% | |